Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_assertion type Assertion NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_head.
- NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_assertion description "[The most remarkable difference was observed in the tumoral vessels: in invasive ductal carcinoma MAb BC-1 revealed a positive reaction with vessels in 78% of cases while FDC-6 showed such a reaction in only 59% of cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_provenance.
- NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_assertion evidence source_evidence_literature NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_provenance.
- NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_assertion SIO_000772 7927891 NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_provenance.
- NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_assertion wasDerivedFrom befree-20140225 NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_provenance.
- NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_assertion wasGeneratedBy ECO_0000203 NP590315.RAEgMd7-UPZI6g9-48YsPoPJ__2DSM9GNV8r2EBlalNCI130_provenance.